Giant prevention study has sobering message
(Source: ScienceNOW)
Source: ScienceNOW - March 14, 2019 Category: Science Authors: Cohen, J. Tags: Epidemiology, Virology In Depth Source Type: news

Has a second person with HIV been cured?
(Source: ScienceNOW)
Source: ScienceNOW - March 7, 2019 Category: Science Authors: Cohen, J. Tags: Epidemiology, Virology In Depth Source Type: news

Did Black Death strike sub-Saharan Africa?
(Source: ScienceNOW)
Source: ScienceNOW - March 7, 2019 Category: Science Authors: Wade, L. Tags: Epidemiology, Immunology, Virology In Depth Source Type: news

Vaccination opponents target CDC panel
(Source: ScienceNOW)
Source: ScienceNOW - March 7, 2019 Category: Science Authors: Wadman, M. Tags: Epidemiology, Science and Policy, Virology In Depth Source Type: news

These Researchers Are Using Artificial Intelligence to Make a Better Flu Vaccine
The influenza virus is a particularly nasty bug, thanks in no small part to how rapidly it mutates. Every time the flu virus changes, it becomes harder for humans to develop an immunity. Even our best external defense against influenza, the flu shot, is based on experts’ best guess as to which flu strain or strains are most likely to be prevalent during a given flu season. Sometimes they’re right — this season’s vaccine has turned out to be a relatively good match for the strains currently in circulation. But sometimes they get it wrong, potentially leading to a more severe flu season. And influenza...
Source: TIME: Health - March 5, 2019 Category: Consumer Health News Authors: Alejandro de la Garza Tags: Uncategorized Life Reinvented medicine onetime Source Type: news

These Researchers Are Using Artificial Intelligence to Make a Better Flu Vaccine
The influenza virus is a particularly nasty bug, thanks in no small part to how rapidly it mutates. Every time the flu virus changes, it becomes harder for humans to develop an immunity. Even our best external defense against influenza, the flu shot, is based on experts’ best guess as to which flu strain or strains are most likely to be prevalent during a given flu season. Sometimes they’re right — this season’s vaccine has turned out to be a relatively good match for the strains currently in circulation. But sometimes they get it wrong, potentially leading to a more severe flu season. And influenza...
Source: TIME: Science - March 5, 2019 Category: Science Authors: Alejandro de la Garza Tags: Uncategorized Life Reinvented medicine onetime Source Type: news

Uptake, Virological Outcomes of Single vs Multi-Tablet ART Uptake, Virological Outcomes of Single vs Multi-Tablet ART
How do single and multi-tablet ART regimens compare in terms of uptake and virological suppression among youth with HIV?HIV Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 21, 2019 Category: Consumer Health News Tags: HIV/AIDS Journal Article Source Type: news

Nigeria: Lassa Fever - Ebonyi Records Three Deaths, Treats 14 Patients
[Premium Times] The virology centre at the Federal Teaching Hospital, Abakaliki (FETHA) has treated and discharged 14 Lassa fever patients so far this year. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 19, 2019 Category: African Health Source Type: news

Efficacy of Switching to Dolutegravir Plus Emtricitabine/TDF Efficacy of Switching to Dolutegravir Plus Emtricitabine/TDF
Are these two regimens considered safe and effective switch strategies in virologically suppressed HIV patients?HIV Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 7, 2019 Category: Consumer Health News Tags: HIV/AIDS Journal Article Source Type: news

Nigeria: Nigeria Gets $29 Million Global Funds Grant to Fight TB
[Premium Times] The Institute of Human Virology Nigeria (IHVN) on Wednesday says the Global Funds has provided $29 million grant to help fight Tuberculosis (TB) in the country. (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - January 31, 2019 Category: Infectious Diseases Source Type: news

Flu WARNING: Vaccine not ALWAYS effective but COULD mean difference between life or death
FLU season is already having a “high impact” on hospitals across Britain and one virologist has warned the vaccine may, in some cases, not be as effective as it should be in offering immunity to the viral infection. (Source: Daily Express - Health)
Source: Daily Express - Health - January 24, 2019 Category: Consumer Health News Source Type: news

Detection of HSV and VZV by Molecular Methods Detection of HSV and VZV by Molecular Methods
This study compared multiplex nucleic acid amplification tests that detect and differentiate herpes simplex virus and varicella-zoster virus with traditional virologic assays.American Journal of Clinical Pathology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 14, 2019 Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news

Researchers gain control over soft-molecule synthesis
(University of Illinois at Urbana-Champaign) By gaining control over shape, size and composition during synthetic molecule assembly, researchers can begin to probe how these factors influence the function of soft materials. Finding these answers could help advance virology, drug delivery development and the creation of new materials. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - January 14, 2019 Category: Biology Source Type: news

HIV Virological Failure During DTG Maintenance Monotherapy HIV Virological Failure During DTG Maintenance Monotherapy
Which factors may be associated with virological failure during dolutegravir monotherapy for HIV?HIV Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 10, 2019 Category: Consumer Health News Tags: HIV/AIDS Journal Article Source Type: news

Mobile, instant diagnosis of viruses
(Cirad) In a first for plant virology, a team from CIRAD recently used nanopore technology to sequence the entire genomes of two yam RNA viruses. This as yet little-used but promising molecular biology technique paves the way for new tools for field diagnosis of plant, animal and human diseases. A godsend for developing countries... (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - January 10, 2019 Category: Biology Source Type: news

Flu symptoms: Expert warns of SIX key things you MUST do to prevent getting FLU
FLU season is underway across Britain and virologist Connor Bamford has outlined six key ways to prevent catching and spreading the common winter illness. (Source: Daily Express - Health)
Source: Daily Express - Health - January 3, 2019 Category: Consumer Health News Source Type: news

Flu symptoms: Virologist explains these KEY differences between flu and the common cold
FLU season has set in across Britain and virologist Dr Connor Bamford has outlined the key differences between the influenza virus and the common cold as symptoms often overlap, making it hard to tell which is which. (Source: Daily Express - Health)
Source: Daily Express - Health - December 21, 2018 Category: Consumer Health News Source Type: news

New Field Test Discerns Between Ebola and Lookalike Fevers
At the close of the 2014-2016 West Africa Ebola crisis, the Paul G. Allen Foundation identified diagnostic gaps as one of the major deficiencies that had contributed to the outbreak’s spread. “The standard diagnostic tests that exist are very good, but they’re hard to do out in the field in the middle of an outbreak like we saw in West Africa,” said John Connor, a virologist at the Boston University National Emerging Infectious Diseases Laboratory (NEIDL). Instead, samples need to be sent to a facility capable of running the tests, which means it could...
Source: MDDI - December 13, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: IVD Source Type: news

Institute of Human Virology researchers discover that a bacterial protein promotes cancer
(University of Maryland School of Medicine) The Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) announced today the discovery that DnaK, a protein of the bacterium mycoplasma, interferes with the mycoplasma-infected cell's ability to respond to and repair DNA damage, a known origin of cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 4, 2018 Category: International Medicine & Public Health Source Type: news

DAAs Best for Cutting CVD Risk in HCV
(MedPage Today) -- Older treatments and sustained virological responses also tied to lower CVD risk (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - November 19, 2018 Category: Gastroenterology Source Type: news

Liver Disease Risk Factors in Patients Treated for Alcohol and Drug Dependence
Conclusion As this was only a pilot study, further data collection involving a larger, representative sample of clients should be undertaken to explore these results further. References Bennett, H. et al., 2015. Assessing the Long-Term Impact of Treating Hepatitis C Virus (HCV)-Infected People Who Inject Drugs in the UK and the Relationship between Treatment Uptake and Efficacy on Future Infections. PLoS ONE, 10(5), p.e0125846. Edeghere, O. et al., 2015. Retrospective cohort study of liver transplantation in the United Kingdom between 1994 and 2010: the impact of hepatitis C infection. Public Health, 129(5), pp.509–5...
Source: Alcohol Research UK - November 15, 2018 Category: Addiction Authors: admin Tags: Alcohol Insights Source Type: news

The Critical Role EMS Plays in Fighting the Flu
Influenza has been impacting public health on a global scale since the beginning of recorded history. Influenza, also known as the “flu,” has numerous organizations committed to public health research, developing vaccines, and educating best practices preparing for the upcoming flu season. By gaining an understanding of the flu through history, virology, and how it impacts our society, we can have a better appreciation for the commitment that’s involved with combating the flu. What Is Influenza (and What’s Not)? The eyes of an epidemiologist can twitch for a variety of reasons, one of them being whe...
Source: JEMS Operations - November 8, 2018 Category: Emergency Medicine Authors: Morgan K. Anderson, MPH Tags: Exclusive Articles Operations Source Type: news

The Critical Role EMS Plays in Fighting the Flu
Influenza has been impacting public health on a global scale since the beginning of recorded history. Influenza, also known as the “flu,” has numerous organizations committed to public health research, developing vaccines, and educating on best practices to prepare for the upcoming flu season. By gaining an understanding of the flu through history, virology, and how it impacts our society, we can have a better appreciation for the commitment that’s involved with combating the flu. What Is Influenza (and What’s Not)? The eyes of an epidemiologist can twitch for a variety of reasons, one of them being...
Source: JEMS Special Topics - November 8, 2018 Category: Emergency Medicine Authors: Morgan K. Anderson, MPH Tags: Exclusive Articles Operations Source Type: news

Physicists explain how large spherical viruses form
(University of California - Riverside) A team of physicists and a virologist, led by a scientist at the University of California, Riverside, explains how large virus shells are formed. Their work can also be used also to explain how large spherical crystals form in nature. This understanding may help researchers interrupt viruses' formation, containing the spread of viral diseases. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 2, 2018 Category: Infectious Diseases Source Type: news

Molecular virologist fights influenza at the molecular level
(University of Alabama at Birmingham) In research to improve influenza therapies against H7N9 and other influenza strains, Chad Petit and his University of Alabama at Birmingham colleagues have detailed the binding site and mechanism of inhibition for two small-molecule experimental inhibitors of influenza viruses. Their report is published in the Journal of Biochemistry, (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 2, 2018 Category: Infectious Diseases Source Type: news

Novel Agent for Refractory HIV Patients Hits the Mark
(MedPage Today) -- Fostemsavir maintained virologic response through week 48 in ongoing phase III trial (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - November 1, 2018 Category: Infectious Diseases Source Type: news

Diving for Data
Discussion around this is definitely part of the public discourse now but this is going to turn slowly like an ocean liner as incentives become more aligned.“The reimbursement of volume-based agreements is such a complex calculation to unwind, and people acknowledge that it is sensible but a hard thing to do. It takes a lot to move people off tried-and-true, low-risk ways of measuring the performance of a drug.Related Content: Rid Yourself Of Dirty DataTalking The Same LanguageNavigating the ChaosSeeking the Holy Grail of RWEThe Naked Truth About Outcomes-Based PricingPrimary Event: Value Summit USA 2018Pr ...
Source: EyeForPharma - October 16, 2018 Category: Pharmaceuticals Authors: Andrew Stone Source Type: news

Space Oddities: Changing Microbiomes in the Final Frontier
(MedPage Today) -- A virologist-turned-astronaut's most interesting research may be outside the lab (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - October 5, 2018 Category: American Health Source Type: news

Janssen Reports Switching to SYMTUZA ™ Results in Maintained High Virologic Suppression and No Resistance Development up to 96-Weeks in Virologically Suppressed Adults with HIV-1
(Source: Johnson and Johnson)
Source: Johnson and Johnson - October 3, 2018 Category: Pharmaceuticals Source Type: news

Combination therapy targets latent reservoir of HIV
(Beth Israel Deaconess Medical Center) In a new study, Dan H. Barouch, MD, PhD, Director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center, and colleagues demonstrate that administering broadly neutralizing antibodies (bNAb) designed to target HIV in combination with agents that stimulate the innate immune system delayed viral rebound following discontinuation of ART in monkeys. The findings suggest that this two-pronged approach represents a potential strategy for targeting the viral reservoir. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 3, 2018 Category: Infectious Diseases Source Type: news

David A. Leib Named Chair of the Dept. of Microbiology & Immunology at the Geisel School of Medicine at Dartmouth
David A. Leib, PhD, has been named the Chair of the Department of Microbiology and Immunology at Dartmouth’s Geisel School of Medicine. Since joining Dartmouth in 2009, Leib has built a successful research program focusing on discovery and elucidation of new vaccines and therapeutics for neonatal herpesvirus infections. In addition to his research efforts, Leib also teaches undergraduate and graduate courses in virology at Dartmouth. (Source: News at Dartmouth Medical School)
Source: News at Dartmouth Medical School - September 19, 2018 Category: Hospital Management Authors: Derik Hertel Tags: Insider News Press Release Research chair David Leib faculty appointment Home-feature Microbiology and Immunology Source Type: news

Deadly disease monkeypox infects 10% of people who come into contact with sufferers
EXCLUSIVE A professor of virology at Brown University warned hospital staff are most at risk. Public Health England has confirmed a man has been diagnosed with the condition. (Source: the Mail online | Health)
Source: the Mail online | Health - September 10, 2018 Category: Consumer Health News Source Type: news

South Africa:SA Branch Chief At Us Centres for Disease Control Appears in Cape Town Court
[Daily Maverick] Zimbabwe-born US citizen, virologist and South African branch chief at the US Centres for Disease Control and Prevention, Dr Alfred Bere. (Photo from a social media profile) (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 4, 2018 Category: African Health Source Type: news

Inovio launches Ph1 study of Hep C vaccine
Inovio Pharmaceuticals (NSDQ:INO) and its partner, GeneOne Life Science (KSE:011000), said today that the companies have dosed the first patient in a Phase I study designed to test a preventive vaccine against hepatitis C infection. The companies plan to recruit 24 study participants to evaluate Inovio’s GLS-6150 candidate. Participants will include people who have a sustained virologic response following treatment for Hep. C, as well as healthy controls. They are slated to receive one of two doses of vaccine, administered intra-dermally and followed by electroporation with Inovio’s Cellectra device. Get t...
Source: Mass Device - September 4, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Pharmaceuticals Wall Street Beat Inovio Pharmaceuticals Source Type: news

The reemergence of yellow fever
(Source: ScienceNOW)
Source: ScienceNOW - August 30, 2018 Category: Science Authors: Barrett, A. D. T. Tags: Virology perspective Source Type: news

Liver-Fibrosis Regression Seen After Hepatitis C Cure Liver-Fibrosis Regression Seen After Hepatitis C Cure
Liver fibrosis regresses in some patients with chronic hepatitis C infection who achieve a sustained virological response (SVR) to oral direct-acting antivirals (DAA), according to a retrospective study.Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - August 29, 2018 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Impact of SVR on Risk of T2DM Among HCV Patients in the US Impact of SVR on Risk of T2DM Among HCV Patients in the US
Does achieving sustained virologic response lower the risk for development of type 2 diabetes mellitus in patients with hepatitis C?Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 28, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Ebola death toll in the Democratic Republic of Congo jumps to 55
Virologists have already warned the situation in the east of the country is ‘hard to control’ because the cases are in a conflict zone, roamed by armed militias. (Source: the Mail online | Health)
Source: the Mail online | Health - August 21, 2018 Category: Consumer Health News Source Type: news

The US Domestic Influenza Virologic Surveillance Landscape The US Domestic Influenza Virologic Surveillance Landscape
The development of a process map characterizing the landscape of US influenza virologic surveillance may help improve pandemic planning and response efforts.Emerging Infectious Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 15, 2018 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news

UC Davis researchers find quiet viruses alter body's response to vaccines, pathogens
(University of California - Davis Health System) UC Davis researchers have shown that low levels of cytomegalovirus (CMV) have a significant impact on microbe and immune cell populations and how the immune system responds to the influenza vaccine. The study was published in the Journal of Virology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 3, 2018 Category: International Medicine & Public Health Source Type: news

Nigeria:Plateau Virology Research Centre Gets Rare International Accreditation
[This Day] Jos -The Plateau State Human Virology Research Centre (PLASVIREC) laboratory has gotten international accreditation from the International Standards Organisation (ISO) in recognition of its standard medical laboratory science practices and procedures. PLASVIREC was initiated for the implementation of HIV surveillance, research, testing, and prevention activities in Nigeria, as well as Early Infant Diagnosis, molecular techniques, clinical trials, cohort studies and provision of technical support/training. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 2, 2018 Category: African Health Source Type: news

'Ending AIDS movement falters worldwide
(Source: ScienceNOW)
Source: ScienceNOW - August 2, 2018 Category: Science Authors: Cohen, J. Tags: Epidemiology, Medicine, Diseases, Virology In Depth Source Type: news

Active substance raises hopes of curing hepatitis E
(Ruhr-University Bochum) An international team of researchers has now found a possible active substance against the virus in the naturally occurring substance silvestrol. The substance inhibited the replication of pathogens both in cell culture and in the mouse model. The researchers led by Dr Daniel Todt and Prof Dr Eike Steinmann from the Department of Medical and Molecular Virology at Ruhr-Universit ä t Bochum (RUB) reported in the journal " Antiviral Research " on 23 July 2018. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 1, 2018 Category: International Medicine & Public Health Source Type: news

Benefits of early antiretroviral therapy in HIV-infected children
(Institut Pasteur) The initial findings of the ANRS CLEAC study coordinated by Pierre Frange (H ô pital Necker -- AP-HP), help define the immunological and virological benefits of early antiretroviral therapy in HIV-infected children living in France. The results of this study will be presented by Florence Buseyne (Oncogenic Virus Epidemiology& Pathophysiology Team -- Institut Pasteur) this Wednesday, July 25 at the 22nd International AIDS Conference (AIDS 2018) being held in Amsterdam from July 23 to 26, 2018. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - July 25, 2018 Category: Biology Source Type: news

Congo rapidly curtails Ebola
(Source: ScienceNOW)
Source: ScienceNOW - July 19, 2018 Category: Science Authors: Cohen, J. Tags: Epidemiology, Medicine, Diseases, Virology In Depth Source Type: news

FDA Approves Symtuza for Treatment of HIV FDA Approves Symtuza for Treatment of HIV
The FDA has approved the first protease inhibitor-based single-tablet regimen for the treatment of HIV-1 infection in treatment-naive and certain virologically suppressed adult patients.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 19, 2018 Category: Consumer Health News Tags: HIV/AIDS News Alert Source Type: news

Fixed-Dose Bictegravir-Emtricitabine-Tenofovir Maintains Virologic Suppression in HIV Fixed-Dose Bictegravir-Emtricitabine-Tenofovir Maintains Virologic Suppression in HIV
Fixed-dose bictegravir-emtricitabine-tenofovir (Biktarvy) maintains virologic suppression in adults with HIV-1 who are switched from dolutegravir-abacavir-lamivudine or from boosted protease inhibitor-based regimens, according to results from two noninferiority trials.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 13, 2018 Category: Consumer Health News Tags: HIV/AIDS News Source Type: news

Thermo Scientific Krios Cryo-TEM instrument installed at the Institut Pasteur
(Institut Pasteur) The Institut Pasteur officially unveiled its new Thermo Scientific Krios Cryo-TEM electron microscope at an event in Paris, France, on July 12, 2018. The availability of one of the most powerful microscopes in the world in the center of Paris will allow structural biologists to extend their research in areas such as immunology, bacteriology, virology, parasitology and neuroscience.By acquiring the Krios Cryo-TEM system, the Institut Pasteur is offering its scientists a closer look at life. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 13, 2018 Category: International Medicine & Public Health Source Type: news

Polio outbreaks in the DRC threaten eradication effort
(Source: ScienceNOW)
Source: ScienceNOW - July 5, 2018 Category: Science Authors: Roberts, L. Tags: Epidemiology, Medicine, Diseases, Virology In Depth Source Type: news

Nigeria:Why Nigeria Cannot Start Producing Vaccines Now - Professor of Virology
[Premium Times] Oyewale Tomori is a professor of virology, educational administrator and former vice chancellor. He is a fellow of the Academy of Science of Nigeria, fellow of the College of Veterinary Surgeons of Nigeria and fellow of the Royal College of Pathologists of the United Kingdom. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 3, 2018 Category: African Health Source Type: news